Further research has revealed that KLF2 can bind to the promoter of GPX4 in ccRCC, leading to the downregulation of GPX4 expression, which protects ccRCC cells from ferroptosis, thus promoting tumor cell metastasis (255). The gene discussed is KLF2; the disease is nonpapillary renal cell carcinoma.